FI920566A - Förfarande för framställning av terapeutiskt användbara 9-aminotetrahydroakridiner - Google Patents

Förfarande för framställning av terapeutiskt användbara 9-aminotetrahydroakridiner Download PDF

Info

Publication number
FI920566A
FI920566A FI920566A FI920566A FI920566A FI 920566 A FI920566 A FI 920566A FI 920566 A FI920566 A FI 920566A FI 920566 A FI920566 A FI 920566A FI 920566 A FI920566 A FI 920566A
Authority
FI
Finland
Prior art keywords
hydrogen
loweralkyl
preparation
aminotetrahydroacridines
derivatives
Prior art date
Application number
FI920566A
Other languages
English (en)
Finnish (fi)
Other versions
FI96308C (sv
FI96308B (sv
FI920566A0 (sv
Inventor
Gregory Michael Shutske
Kevin James Kapples
John Dick Tomer
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of FI920566A0 publication Critical patent/FI920566A0/sv
Publication of FI920566A publication Critical patent/FI920566A/sv
Application granted granted Critical
Publication of FI96308B publication Critical patent/FI96308B/sv
Publication of FI96308C publication Critical patent/FI96308C/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D219/00Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • C07F7/0814Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring is substituted at a C ring atom by Si
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D219/00Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08Nitrogen atoms
    • C07D219/10Nitrogen atoms attached in position 9
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/12Organo silicon halides

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
FI920566A 1991-02-13 1992-02-11 Förfarande för framställning av terapeutiskt användbara 9-aminotetrahydroakridiner FI96308C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65469191 1991-02-13
US07/654,691 US5210087A (en) 1991-02-13 1991-02-13 9-aminotetrahydroacridines and related compounds

Publications (4)

Publication Number Publication Date
FI920566A0 FI920566A0 (sv) 1992-02-11
FI920566A true FI920566A (sv) 1992-08-14
FI96308B FI96308B (sv) 1996-02-29
FI96308C FI96308C (sv) 1996-06-10

Family

ID=24625869

Family Applications (2)

Application Number Title Priority Date Filing Date
FI920566A FI96308C (sv) 1991-02-13 1992-02-11 Förfarande för framställning av terapeutiskt användbara 9-aminotetrahydroakridiner
FI945854A FI97056C (sv) 1991-02-13 1994-12-13 6,7-dihydro-3-(2-nitrofenyl)bensisoxazol-4(5H)-oner och förfarande för framställning av dessa

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI945854A FI97056C (sv) 1991-02-13 1994-12-13 6,7-dihydro-3-(2-nitrofenyl)bensisoxazol-4(5H)-oner och förfarande för framställning av dessa

Country Status (25)

Country Link
US (3) US5210087A (sv)
EP (1) EP0499231B1 (sv)
JP (1) JPH07121915B2 (sv)
KR (1) KR100223132B1 (sv)
AT (1) ATE153331T1 (sv)
AU (1) AU664165B2 (sv)
BR (1) BR9200475A (sv)
CA (1) CA2061084A1 (sv)
CZ (1) CZ281927B6 (sv)
DE (1) DE69219801T2 (sv)
DK (1) DK0499231T3 (sv)
ES (1) ES2102417T3 (sv)
FI (2) FI96308C (sv)
GR (1) GR3024310T3 (sv)
HU (1) HU219451B (sv)
IE (1) IE920459A1 (sv)
IL (3) IL117795A (sv)
MX (1) MX9200607A (sv)
NO (1) NO177933C (sv)
NZ (3) NZ241586A (sv)
PL (6) PL168906B1 (sv)
RO (1) RO112354B1 (sv)
RU (1) RU2083564C1 (sv)
TW (1) TW221426B (sv)
ZA (1) ZA921004B (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210087A (en) * 1991-02-13 1993-05-11 Hoechst-Roussel Pharmaceuticals Inc. 9-aminotetrahydroacridines and related compounds
ES2059263B1 (es) * 1992-10-27 1995-10-01 Vita Invest Sa Procedimiento para la obtencion del (+)-9-amino-1,2,3,4-tetrahidroacridin-1-ol.
US5434170A (en) * 1993-12-23 1995-07-18 Andrulis Pharmaceuticals Corp. Method for treating neurocognitive disorders
ES2144353B1 (es) * 1997-12-26 2001-01-01 Consejo Superior Investigacion Nuevos analogos de tacrina: potenciales agentes neuroprotectores para las enfermedades de alzheimer y parkinson. su procedimiento de obtencion.
EP1484325B1 (en) * 2002-03-08 2014-06-18 Japan Science and Technology Agency Isoxazole derivatives and process for producing the same
RU2616247C1 (ru) * 2016-03-28 2017-04-13 Федеральное государственное бюджетное образовательное учреждение высшего образования "Северо-Осетинский государственный университет имени Коста Левановича Хетагурова" (СОГУ) Твердая лекарственная форма, обладающая холинопозитивным действием, на основе 9-бутиламино-3,3-диметил-1,2,4-тригидроакридина

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3232945A (en) * 1962-08-13 1966-02-01 S E Massengill Company 7,8,9,10-tetrahalo-6h-cyclohepta-(b)-quinolines
US4631286A (en) * 1984-10-25 1986-12-23 Hoechst-Roussel Pharmaceuticals Inc. 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds
US4695573A (en) * 1984-10-25 1987-09-22 Hoechst-Roussel Pharmaceuticals Inc. 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds
DE3582995D1 (de) * 1984-10-25 1991-07-04 Hoechst Roussel Pharma 9-amino-1,2,3,4-tetrahydroacridin-1-ol und verwandte verbindungen, verfahren zu ihrer herstellung und verwendung als arzneimittel.
MX13270A (es) * 1987-10-05 1993-06-01 Pfizer Procedimiento para la preparacion de derivados de 4-aminopiridina
IL87861A0 (en) * 1987-10-05 1989-03-31 Pfizer 4-aminopyridine derivatives
GB8827704D0 (en) * 1988-11-28 1988-12-29 Fujisawa Pharmaceutical Co New acridine derivatives & processes for their production
US5441727A (en) * 1989-06-21 1995-08-15 The Procter & Gamble Company Diketone deodorant composition and method of deodorization
US5053513A (en) * 1990-03-29 1991-10-01 Hoechst-Roussel Pharmaceuticals Incorporated Method of reducing a carbonyl containing acridine
US5210087A (en) * 1991-02-13 1993-05-11 Hoechst-Roussel Pharmaceuticals Inc. 9-aminotetrahydroacridines and related compounds
GB2264707A (en) * 1991-06-18 1993-09-08 Roger Michael Marchbanks Acridine derivatives for treating alzheimer's disease

Also Published As

Publication number Publication date
DK0499231T3 (da) 1997-12-01
FI945854A (sv) 1994-12-13
NZ260694A (en) 1996-02-27
AU664165B2 (en) 1995-11-09
NO920547D0 (no) 1992-02-12
PL168153B1 (pl) 1996-01-31
NZ270647A (en) 1996-02-27
FI945854A0 (sv) 1994-12-13
BR9200475A (pt) 1992-10-20
NZ241586A (en) 1996-02-27
AU1090392A (en) 1992-08-20
US5382594A (en) 1995-01-17
ATE153331T1 (de) 1997-06-15
PL296320A1 (en) 1993-07-12
ZA921004B (en) 1992-10-28
DE69219801D1 (de) 1997-06-26
US5210087A (en) 1993-05-11
TW221426B (sv) 1994-03-01
JPH04312578A (ja) 1992-11-04
PL293443A1 (en) 1993-03-08
HU9200423D0 (en) 1992-04-28
IL117795A0 (en) 1996-08-04
NO177933C (no) 1995-12-20
IL100921A (en) 1998-12-27
CZ281927B6 (cs) 1997-04-16
NO177933B (no) 1995-09-11
DE69219801T2 (de) 1997-11-27
KR100223132B1 (ko) 1999-10-15
IL117795A (en) 1998-01-04
RU2083564C1 (ru) 1997-07-10
MX9200607A (es) 1992-11-30
RO112354B1 (ro) 1997-08-29
PL296319A1 (en) 1993-07-12
FI96308C (sv) 1996-06-10
EP0499231B1 (en) 1997-05-21
KR920016426A (ko) 1992-09-24
GR3024310T3 (en) 1997-10-31
PL168906B1 (pl) 1996-05-31
EP0499231A1 (en) 1992-08-19
PL168862B1 (pl) 1996-04-30
ES2102417T3 (es) 1997-08-01
FI96308B (sv) 1996-02-29
HU219451B (hu) 2001-04-28
CS42692A3 (en) 1992-09-16
US5502203A (en) 1996-03-26
JPH07121915B2 (ja) 1995-12-25
CA2061084A1 (en) 1992-08-14
FI97056C (sv) 1996-10-10
NO920547L (no) 1992-08-14
FI920566A0 (sv) 1992-02-11
HUT67032A (en) 1995-01-30
FI97056B (sv) 1996-06-28
PL169095B1 (pl) 1996-05-31
PL168861B1 (pl) 1996-04-30
IE920459A1 (en) 1992-08-12
PL166939B1 (pl) 1995-07-31

Similar Documents

Publication Publication Date Title
FI96308C (sv) Förfarande för framställning av terapeutiskt användbara 9-aminotetrahydroakridiner
ZA898498B (en) 1,2,3,4-tetrahydro-1,9-acridinediamines,a process for their preparation and their use as medicaments
FI103970B1 (sv) Förfarande för framställning av 3-(1,2-bensisoxazol-3-yl)-4-pyridinamin och dess derivat, vilka är användbara för lindring av smärta och behandling av hudsjukdomer och funktionstörningar i minnet
NO179583C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 1-(pyridinylalkyl)-1H-indoler
ZA898989B (en) Fused heterocyclic derivatives of 1,2,3,4-tetrahydroacridine,a process for their preparation and their use as medicaments
IL94664A0 (en) 4,5,5a,6-tetrahydro-3h-isoxazolo(5,4,3-ki)acridine derivatives,process for their preparation and their use as medicaments

Legal Events

Date Code Title Description
BB Publication of examined application
PC Transfer of assignment of patent

Owner name: HOECHST MARION ROUSSEL, INC.